Management of Patients with Community-acquired Pneumonia Treated in Hospital in Sweden

References

• Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Karkola K, Korppi M, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137: 977–88.
   PubMed Web of Science ®Google Scholar
• Marrie T. Community-acquired pneumonia. J Clin Infect Dis 1994; 18: 501–13.
   PubMed Web of Science ®Google Scholar
• Woodhead MA, Macfarlane JT. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; i: 671–4.
   Google Scholar
• Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther 1998; 20: 820–37.
   Google Scholar
• British Thoracic Society. BTS guidelines for the management of community-acquired pneumonia in adults. Thorax 2001; 56 (Suppl IV): iv1–64.
   Google Scholar
• Marston BJ, Plouffe JE, File TM, Hackman BA, Salstrom S-J, Lipman HB, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Arch Intern Med 1997; 157: 1709–18.
   Google Scholar
• American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418–26.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730–54.
   Google Scholar
• Bartlett JG, Breiman RF, Mandell LA, File TM. Communityacquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26: 811–38.
   PubMed Web of Science ®Google Scholar
• Bartlett JG, Dowell SF, Mandell LA, File TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31: 347–82.
   PubMed Web of Science ®Google Scholar
• Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance. Arch Intern Med 2000; 160: 1399–408.
   PubMed Web of Science ®Google Scholar
• Mandell LA, Niederman M. Antimicrobial treatment of community-acquired pneumonia in adults: a conference report. Can J Infect Dis 1993; 4: 25–8.
   PubMedGoogle Scholar
• Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31: 383–421.
   Google Scholar
• British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 1993; 49: 346–50.
   PubMed Web of Science ®Google Scholar
• European Study on Community Acquired Pneumonia (ESOCAP) Committee. Management of adult community-acquiredlower respiratory tract infections. Eur Respir Rev 1998; 8: 391–426.
   Google Scholar
• Huchon GJ, Gialdroni-Grassi G, Léophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J 1996; 9: 1590–5.
   PubMed Web of Science ®Google Scholar
• Örtqvist A. In-hospital management of adults who have community-acquired pneumonia. Semin Respir Infect 1999; 14: 135–50.
   PubMedGoogle Scholar
• Örtqvist Å. Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective. J Antimicrob Chemother 1995; 35: 205–12.
   PubMedGoogle Scholar
• Mölstad S, Stålsby Lundborg C, Karlsson A-K, Cars O. Antibiotic prescription rates vary markedly between 13 European countries. Scand J Infect Dis 2002; 34: 366–71.
   PubMed Web of Science ®Google Scholar
• Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851–3.
   PubMed Web of Science ®Google Scholar
• Kirk O, Glenthöj J, Dragsted UB, Helweg-Larsen J, Aru TM, Benfield TL, et al. Penicillin as empirical therapy for patients hospitalized with community-acquired pneumonia at a Danish hospital. Dan Med Bull 2001; 48: 84–8.
   PubMedGoogle Scholar
• Stahl JE, Barza M, DesJardin J, Martin R, Eckman MH. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 1999; 159: 2576–80.
   Google Scholar
• Gleason PP, Kapoor WN, Stone RA, Lave JR, Obrosky DS, Schulz R, et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA 1997; 278: 32–9.
   PubMed Web of Science ®Google Scholar
• Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159: 2562–72.
   Google Scholar
• Houck PM, MacLehose MS, Niederman MS, Lowery JK. Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 western states. Chest 2001; 119: 1420–6.
   PubMed Web of Science ®Google Scholar
• Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001; 161: 1837–42.
   Google Scholar
• McCormick D, Fine MJ, Coley CM, Marrie TJ, Lave JR, Obrosky S, Kapoor WN. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am J Med 1999; 107: 5–12.
   Google Scholar
• Halm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN, Obrosky S, Singer DE. Time to clinical stability in patients hospitalized with community-acquired pneumonia. Implications for practice guidelines. JAMA 1998; 279: 1452–7.
   Google Scholar
• Fine MJ, Singer DE, Phelps AL, Hanusa BH, Kapoor WN. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med Care 1993; 31: 371–80.
   Google Scholar
• Fine MJ, Singer DE, Hanusa BH, Lave JR, Kapoor WN. Validation of a pneumonia prognostic index using the Medis-Groups Comparative Hospital Database. Am J Med 1993; 94: 153–9.
   Google Scholar
• Feagan BG, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. Can Med Assoc J 2000; 162: 1415–20.
   Google Scholar
• Örtqvist Å, Hedlund J, Wretlind B, Carlström A, Kalin M. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis 1995; 27: 457–62.
   Google Scholar
• Meehan TP, Fine MJ, Krumholz HM, Scinto JD, Galusha DH, Mockalis JT, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278: 2080–4.
   PubMed Web of Science ®Google Scholar
• Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243–50.
   PubMed Web of Science ®Google Scholar
• Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR, et al. Processes and outcomes of care for patients with community-acquired pneumonia. Results from the pneumonia patients outcomes research team (PORT) cohort study. Arch Intern Med 1999; 159: 970–80.
   Google Scholar
• Harrison BDW, Farr BM, Pugh S, Selkon JB. Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med New Series 1987; 62: 195–220.
   PubMedGoogle Scholar
• Hedlund J, Örtqvist Å, Kalin M. Nasopharyngeal culture in the pneumonia diagnosis. Infection 1990; 18: 283–5.
   PubMed Web of Science ®Google Scholar
• Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275: 134–41.
   Google Scholar
• Mundy L, Oldach D, Auwaerter PG, Gaydos CA, Moore RD, Bartlett JG, Quinn TC. Implications for macrolide treatment in community-acquired pneumonia. Chest 1998; 113: 1201–6.
   Google Scholar
• Kalin M, Örtqvist Å, Almela M, Aufwerber E, Dwyer R, Henriques B, et al. Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 2000; 182: 840–7.
   PubMed Web of Science ®Google Scholar
• Örtqvist Å, Kalin M, Julander I, Mufson M. Deaths in bacteremic pneumococcal pneumonia. Chest 1993; 103: 710–6.
   Google Scholar
• Burns LR, Wholey DR. The effects of patient, hospital, and physician characteristics on length of stay and mortality. Med Care 1991; 29: 251–71.
   PubMed Web of Science ®Google Scholar
• Lave JR, Leinhardt S. The cost and length of a hospital stay. Inquiry 1976; 13: 327–43.
   PubMedGoogle Scholar
• Sanyal S, Smith PR, Saha AC, Gupta S, Berkowitz L, Homel P. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am J Respir Crit Care Med 1999; 160: 346–8.
   PubMed Web of Science ®Google Scholar
• Chalasani NP, Valdecanas MAL, Gopal AK, McCowan JE, Jurado RL. Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks. Chest 1995; 108: 932–6.
   Google Scholar